SSG
PAHC icon

Summit Securities Group’s Phibro Animal Health PAHC Stock Holding History

Summit Securities Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-706
Closed -$18K – 1273
2025
Q2 		$18K Buy
+706
New +$15.4K ﹤0.01% 748
2024
Q3 		– Sell
-4,966
Closed -$83K – 782
2024
Q2 		$83K Buy
+4,966
New +$79.8K 0.02% 238

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit Securities Group's PAHC Position: Q3 2025 in Review

Summit Securities Group sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 706 shares — an estimated $18K sold.

Summit Securities Group first reported a position in PAHC in Q2 2024 and held it in 2 quarters. The position peaked at $83K in Q2 2024. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

  • Summit Securities Group reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
  • Summit Securities Group sold 706 Phibro Animal Health shares in Q3 2025, an estimated $18K.
  • Summit Securities Group first reported a position in Phibro Animal Health in Q2 2024 and held it in 2 quarters.
  • Summit Securities Group's Phibro Animal Health position peaked at $83K in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Summit Securities Group's 13F filing for Q3 2025, filed 13 Nov 2025.